x

ALX ONCOLOGY HOLDINGS INC (Nasdaq:ALXO)

Health Care/Life Sciences • Pharmaceuticals
CIK 1810182
Company

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Address
323 Allerton Avenue
South San Francisco, California 94080
Employees
58
Stock Info
Close
$14.77
Day Range
14.44 - 14.94
52 Week Range
3.94 - 17.42
Average volume
450.99K
Short Interest
3.53M (02/15/24)
% of Float Shorted
13.07%
Market Cap
$732.34M
Revenue
N/A
Net Income
-$123.48M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.57
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Director & Chief Scientific Officer
Jaume Pons PhD
Chief Executive Officer & Director
Jason Lettmann MBA
Director & Chief Medical Officer
Sophia Randolph MD, PhD
Director
J Scott Garland MBA
Executive Chairman
Corey S Goodman PhD
Independent Director
Itziar Canamasas PhD
Non-Executive Independent Director
Rekha Hemrajani MBA
Independent Director
Jack Bech Nielsen
SEC filings
DateFormEvent
6 Dec, 2024 SCHEDULE 1
4 Dec, 2024 4
4 Dec, 2024 4
4 Dec, 2024 4
2 Dec, 2024 SC TO-I
19 Nov, 2024 4
14 Nov, 2024 SC 13G/A
14 Nov, 2024 8-K
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
12 Nov, 2024 SC 13G/A
7 Nov, 2024 10-Q
7 Nov, 2024 8-K
10 Oct, 2024 SC 13G/A
4 Oct, 2024 8-K
22 Aug, 2024 SC 13G
16 Aug, 2024 4
16 Aug, 2024 4
16 Aug, 2024 4
16 Aug, 2024 4
16 Aug, 2024 4
13 Aug, 2024 SC 13G
12 Aug, 2024 10-Q
8 Aug, 2024 8-K
7 Aug, 2024 4
7 Aug, 2024 3
6 Aug, 2024 8-K
15 Jul, 2024 4
11 Jul, 2024 144
9 Jul, 2024 4
3 Jul, 2024 4
3 Jul, 2024 4
3 Jul, 2024 4
2 Jul, 2024 4
24 Jun, 2024 4/A
17 Jun, 2024 8-K
17 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
6 Jun, 2024 4
4 Jun, 2024 144
15 May, 2024 4
13 May, 2024 144
9 May, 2024 10-Q
9 May, 2024 8-K
8 May, 2024 4
6 May, 2024 144
2 May, 2024 8-K
2 May, 2024 DEFA14A
23 Apr, 2024 ARS
22 Apr, 2024 DEF 14A
18 Apr, 2024 4
16 Apr, 2024 144
5 Apr, 2024 4
4 Apr, 2024 144
18 Mar, 2024 4
8 Mar, 2024 S-8
7 Mar, 2024 8-K
7 Mar, 2024 10-K
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
14 Feb, 2024 SC 13D/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
5 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
26 Dec, 2023 8-K
20 Dec, 2023 SC 13D/A
13 Nov, 2023 10-Q
13 Nov, 2023 8-K
16 Oct, 2023 SC 13G
13 Oct, 2023 SC 13G
6 Oct, 2023 8-K
6 Oct, 2023 424B5
4 Oct, 2023 8-K
4 Oct, 2023 8-K
4 Oct, 2023 424B5
12 Sep, 2023 4
8 Sep, 2023 424B3
8 Sep, 2023 EFFECT
7 Sep, 2023 CORRESP
6 Sep, 2023 8-K CEO Change
6 Sep, 2023 UPLOAD
1 Sep, 2023 S-3
25 Aug, 2023 424B5
10 Aug, 2023 10-Q
10 Aug, 2023 8-K
27 Jul, 2023 4
27 Jul, 2023 4
27 Jul, 2023 4
27 Jul, 2023 4
7 Jul, 2023 4
5 Jul, 2023 4
5 Jul, 2023 4
5 Jul, 2023 4
5 Jul, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
13 Jun, 2023 4
11 May, 2023 8-K
11 May, 2023 10-Q
24 Apr, 2023 DEF 14A
24 Apr, 2023 ARS
13 Mar, 2023 8-K
9 Mar, 2023 10-K
9 Mar, 2023 8-K
9 Mar, 2023 S-8
14 Feb, 2023 SC 13G
9 Feb, 2023 SC 13G/A
3 Jan, 2023 4
3 Jan, 2023 4
3 Jan, 2023 4
3 Jan, 2023 4
20 Dec, 2022 4
29 Nov, 2022 3
29 Nov, 2022 4
29 Nov, 2022 8-K
8 Nov, 2022 8-K
8 Nov, 2022 10-Q
31 Oct, 2022 8-K
10 Aug, 2022 SC 13G/A
9 Aug, 2022 4
9 Aug, 2022 4
9 Aug, 2022 4
9 Aug, 2022 4
8 Aug, 2022 8-K
8 Aug, 2022 10-Q
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 8-K
16 Jun, 2022 4
16 Jun, 2022 4
10 Jun, 2022 SC 13G/A
31 May, 2022 EFFECT
27 May, 2022 POS AM
25 May, 2022 EFFECT
24 May, 2022 CORRESP
13 May, 2022 S-3/A
9 May, 2022 10-Q
9 May, 2022 8-K
22 Apr, 2022 DEF 14A
14 Apr, 2022 3
14 Apr, 2022 4
12 Apr, 2022 8-K
29 Mar, 2022 UPLOAD
25 Mar, 2022 S-3
28 Feb, 2022 10-K
28 Feb, 2022 S-8
28 Feb, 2022 8-K
9 Feb, 2022 SC 13G
8 Feb, 2022 4
7 Feb, 2022 4
4 Feb, 2022 SC 13G/A
1 Feb, 2022 4
17 Dec, 2021 424B5
17 Dec, 2021 8-K
16 Dec, 2021 4
15 Dec, 2021 4
15 Dec, 2021 4
10 Dec, 2021 4
10 Dec, 2021 4
23 Nov, 2021 4
12 Nov, 2021 8-K
12 Nov, 2021 10-Q
20 Oct, 2021 4
20 Oct, 2021 4
19 Oct, 2021 4
12 Oct, 2021 4
7 Oct, 2021 8-K
21 Sep, 2021 4
17 Sep, 2021 4
13 Sep, 2021 4
10 Sep, 2021 SC 13G
27 Aug, 2021 8-K
24 Aug, 2021 4
20 Aug, 2021 4
18 Aug, 2021 4
13 Aug, 2021 S-3ASR
12 Aug, 2021 8-K
12 Aug, 2021 10-Q
11 Aug, 2021 4
3 Aug, 2021 4
3 Aug, 2021 4
3 Aug, 2021 4
3 Aug, 2021 4
20 Jul, 2021 4
14 Jul, 2021 4
22 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 SC 13D/A
15 Jun, 2021 8-K
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
14 Jun, 2021 4
20 May, 2021 4
19 May, 2021 4/A
17 May, 2021 10-Q
17 May, 2021 8-K
11 May, 2021 4
5 May, 2021 4
5 May, 2021 3
4 May, 2021 8-K
29 Apr, 2021 DEF 14A
21 Apr, 2021 4
13 Apr, 2021 4
26 Mar, 2021 4
25 Mar, 2021 8-K
24 Mar, 2021 4
18 Mar, 2021 10-K
18 Mar, 2021 S-8
18 Mar, 2021 8-K
15 Mar, 2021 8-K
12 Mar, 2021 4
29 Jan, 2021 4
28 Jan, 2021 4
7 Dec, 2020 CORRESP
7 Dec, 2020 CORRESP
25 Nov, 2020 UPLOAD
Last update:2024-03-06 12:18:50.576258
ALX ONCOLOGY HOLDINGS INC by TradingView

Sign Up to Subscribe